How Synthetic Bone Grafting Revolutionized Hip and Knee Replacements

Highlights

• Synthetic bone grafting removed the need to harvest a patient’s own bone in many joint replacement procedures, eliminating a second surgical site.
• Autograft harvesting carries documented complication rates, which drove the search for reliable alternatives.
• Ceramic materials including calcium phosphate and hydroxyapatite provide an osteoconductive scaffold that host bone grows into and gradually remodels.
• Handling characteristics and delivery method determine whether graft material actually reaches and stays at the intended site.
• Contemporary spine target needles are built around a specific anatomical objective rather than serving as general-purpose instruments.
• SurGenTec develops graft materials and delivery systems built around controlled placement in orthopedic procedures.

Joint replacement has become one of the most reliable procedures in modern medicine, but the bone work supporting it rarely gets attention outside the operating room. Acetabular defects, tibial bone loss, periprosthetic cysts, and revision cases all require filling voids so that implants seat against something structurally sound. For decades, the answer to that problem meant a second incision and a second recovery for the patient.

Synthetic bone grafting changed that calculation. Instead of harvesting cancellous bone from a patient’s pelvis, surgeons gained access to materials engineered to serve the same scaffolding function, available in whatever quantity a case required. The shift did not happen overnight, and it did not happen because the alternative was theoretically appealing. It happened because the documented cost of harvesting was high enough to justify pursuing something better.

Understanding that transition explains a great deal about how arthroplasty is practiced today, particularly as procedure volumes climb.

Facing the Limitations of Harvested Bone

Autologous bone taken from the patient’s own iliac crest was long considered the reference standard, and for good biological reasons. It contains living cells, growth factors, and mineral scaffold in a single material, with no rejection risk.

The problem was never the graft itself. It was obtaining it. According to the National Library of Medicine, a systematic review found a complication rate of 19.37% following iliac crest bone graft harvesting, covering 1,249 complications across 6,449 patients, with infection, hematoma formation, and fracture among the reported outcomes.

Beyond complication rates, harvesting added operative time, increased blood loss, and created a second site requiring its own postoperative management. Chronic donor site pain proved a persistent complaint in the literature. And in older patients, precisely the population most likely to need joint replacement, available bone stock was often insufficient for larger defects.

Those constraints made the case for synthetic bone grafting compelling well before the materials themselves matured.

Engineering Materials That Bone Recognizes

The central insight behind synthetic grafts is that bone will grow into a scaffold with the right composition, porosity, and surface characteristics, whether or not that scaffold was ever alive.

Calcium phosphate ceramics, particularly hydroxyapatite and beta tricalcium phosphate, approximate the mineral composition of natural bone closely enough that host tissue treats them as a receptive surface. Hydroxyapatite resorbs slowly and provides durable structural presence. Beta tricalcium phosphate resorbs more quickly and is progressively replaced by new bone. Biphasic formulations combine both, tuning the resorption profile to the clinical need.

Porosity matters as much as chemistry. Interconnected pore networks allow cellular migration and vascular ingrowth throughout the graft rather than only at its surface, which is what permits a defect to fill with living bone rather than remaining a foreign body indefinitely.

According to the Global Spine Journal, a systematic review of 30 studies covering 1,332 patients found an overall fusion rate of 86.4% for ceramic products used as a bone graft extender, with ceramics combined with local autograft producing significantly higher fusion rates than other adjuncts.

Why Does This Matter More as Procedure Volumes Rise?

The clinical stakes of graft strategy scale directly with how often these operations are performed, and the trajectory is steep.

According to the American Academy of Orthopedic Surgeons, hip replacements are expected to grow by 174% and knee replacements by 673% over the next 20 years. Growth of that magnitude changes the calculus in several ways at once.

Higher primary volumes mean proportionally more revision cases, and revisions are where bone loss is most severe and graft demand greatest. More procedures also mean more pressure on operating room throughput, making the time saved by eliminating a harvest step meaningful at a system level rather than merely a case level.

Predictability becomes more valuable too. Harvested bone varies with the individual patient’s age, health, and bone quality. Synthetic materials arrive with consistent composition and known handling properties every time, which supports reproducible technique across high case volumes.

Solving the Delivery Problem

Material science addressed what to put in a defect. It did not initially address how to get it there, and that gap proved consequential.

Early synthetic grafts came as granules or blocks that were difficult to place precisely, particularly in the confined and irregularly shaped defects typical of arthroplasty. Material that migrated away from the target site or washed out during irrigation contributed nothing to healing.

Formulation advances changed this. Putties and moldable composites hold their position, conform to irregular geometry, and resist irrigation. Injectable preparations reach defects that cannot be accessed directly. Carriers that maintain cohesion in the presence of blood keep graft where the surgeon placed it.

Delivery instrumentation developed alongside the materials. Controlled dispensing allows graft to be placed incrementally, at depth, and in the correct volume, which matters as much to outcomes as the material’s biological properties. A well-designed graft delivered poorly performs no better than a poor graft.

Advancing Orthopedic Outcomes Through Better Graft Solutions

The move from harvested bone to engineered alternatives reflects a broader pattern in orthopedic surgery: identifying which parts of a procedure impose burden on the patient without contributing to the outcome, then eliminating them. Donor site morbidity was exactly that kind of burden, and synthetic bone grafting removed it for a growing share of cases while preserving the scaffolding function that defect repair requires.

SurGenTec develops graft materials and delivery systems designed around controlled, accurate placement in orthopedic and spine procedures, pairing formulation characteristics with instrumentation that puts material precisely where it belongs. Reach out to discuss how our biologics and delivery technology fit the cases you handle most.

Frequently Asked Questions